Synektik

Synektik EBIT per Share

The EBIT per Share of Synektik (SNT.WA) as of Nov 1, 2026 is 18.41 PLN. In the previous year, EBIT per Share was 12.54 PLN — a change of 46.83% (higher).

EBIT per Share

18.41PLN

YoY

46.83%

Last updated:

EBIT per Share of Synektik is 2025 18.41 PLN. EBIT per Share of Synektik was 2024 12.54 PLN. It decreases by 46.83% higher compared to the previous year.

The Synektik EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2024
12.54 PLN
Jan 1, 2025
18.41 PLN
Jan 1, 2026 (e)
35.63 PLN
Jan 1, 2027 (e)
28.86 PLN
Jan 1, 2028 (e)
33.61 PLN
Jan 1, 2029 (e)
32.63 PLN
Jan 1, 2030 (e)
23.85 PLN
Jan 1, 2031 (e)
0.00 PLN
The Synektik EBIT per Share history
YEAREBIT per ShareYoY
est0.00PLN-100.00%
est23.85PLN-26.92%
est32.63PLN-2.93%
est33.61PLN+16.46%
est28.86PLN-19.00%
est35.63PLN+93.56%
18.41PLN+46.83%
12.54PLN+57.59%
7.96PLN+864.11%
0.83PLN-37.08%
1.31PLN-7.02%
1.41PLN-5.38%
1.49PLN+9.32%
1.36PLN+225.39%
0.42PLN+67.97%
0.25PLN-473.86%
-0.07PLN-110.54%
0.63PLN-50.82%
1.29PLN+4,910.17%
0.03PLN-159.32%
-0.04PLN-116.27%
0.27PLN+68.56%
0.16PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Synektik Stock analysis

What does Synektik do? Synektik SA generates revenue through its PACS software, which enables diagnostic imaging laboratories to operate efficiently. The company also sells medical equipment and provides services through its imaging equipment services center. Synektik SA partners with Siemens and holds a 100% stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o, which it acquired by raising its stake on November 28, 2013. The firm's research laboratory conducts acceptance and specialist tests on X-ray equipment, contributing to its service offerings. The primary buyers of Synektik SA's products include diagnostic imaging laboratories that require PACS software for their operations. Medical equipment is sold to healthcare facilities, while the research laboratory services are utilized by entities needing X-ray equipment testing. The company's partnership with Siemens supports its medical equipment sales and services. Synektik SA's revenue streams are derived from software licensing, medical equipment sales, and specialized testing services. The company's focus on diagnostic imaging solutions and its ownership of Miedzynarodowe Centra Medyczne Inwestycje Sp z o o position it within the medical technology sector, targeting healthcare providers and imaging laboratories. Synektik is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Synektik stock

EBIT per Share of Synektik is 18.41 PLN in 2025.

EBIT per Share of Synektik changed from 12.54 PLN to 18.41 PLN, representing a 46.83% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Synektik since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Synektik

All Key Metrics — Synektik